> top > docs > PMC:7594251 > spans > 38977-39308 > annotations

PMC:7594251 / 38977-39308 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T80070 96-100 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T24520 238-242 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T284 96-100 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T285 238-242 http://purl.obolibrary.org/obo/GO_0005623 denotes cell

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T393 10-14 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T394 146-150 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T395 209-213 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T396 266-270 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T271 0-113 Sentence denotes NMR-based drug discovery can be broadly classified into two groups: chemical and biological (in-cell) categories.
T272 114-234 Sentence denotes One of the principal methods of drug discovery using NMR spectroscopy is called fragment-based drug design (FBDD) [194].
T273 235-331 Sentence denotes In-cell NMR (biological) based drug discovery techniques will be discussed later in this review.